Biofil Chemicals & Pharmaceuticals Limited Total Liabilities
Biofil Chemicals & Pharmaceuticals Limited total liabilities. Based on the latest financial reports, Biofil Chemicals & Pharmaceuticals Limited (BIOFILCHEM) has total liabilities worth Rs340.59 Million INR (≈ $3.68 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check financial resilience of Biofil Chemicals & Pharmaceuticals Limit to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Biofil Chemicals & Pharmaceuticals Limited (2008–2025)
Total liabilities of Biofil Chemicals & Pharmaceuticals Limited from 2008 to 2025. This chart illustrates how Biofil Chemicals & Pharmaceuticals Limited's total liabilities have evolved over time, based on quarterly financial data.
Biofil Chemicals & Pharmaceuticals Limited Competitors by Total Liabilities
The table below lists competitors of Biofil Chemicals & Pharmaceuticals Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
YGL Convergence Bhd
KLSE:0086
|
Malaysia | RM3.59 Million |
|
Athena Resources Ltd
AU:AHN
|
Australia | AU$117.32K |
|
Willow Biosciences Inc
TO:WLLW
|
Canada | CA$3.00 Million |
|
Dangee Dums Limited
NSE:DANGEE
|
India | Rs259.43 Million |
|
Modern Times Group Mtg AB
ST:MTG-A
|
Sweden | Skr8.67 Billion |
|
HIGH QUALITY FOOD
F:L24
|
Germany | €15.27 Million |
|
Tenon Medical Inc
NASDAQ:TNON
|
USA | $11.66 Million |
|
Better Choice Company Inc
NYSE MKT:BTTR
|
USA | $7.32 Million |
Liability Composition Analysis (2008–2025)
This chart breaks down Biofil Chemicals & Pharmaceuticals Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Biofil Chemicals & Pharmaceuticals Limit assets under control.
Liquidity & Leverage Metrics
Biofil Chemicals & Pharmaceuticals Limited Total Liabilities Ratios Explained
Biofil Chemicals & Pharmaceuticals Limited total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.44 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.01 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.60 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.62 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Biofil Chemicals & Pharmaceuticals Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Biofil Chemicals & Pharmaceuticals Limited (2008–2025)
The table below shows the annual total liabilities of Biofil Chemicals & Pharmaceuticals Limited from 2008 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | Rs321.79 Million ≈ $3.48 Million |
+11.42% |
| 2024-03-31 | Rs288.80 Million ≈ $3.12 Million |
+104.76% |
| 2023-03-31 | Rs141.04 Million ≈ $1.53 Million |
+644.44% |
| 2022-03-31 | Rs18.95 Million ≈ $204.89K |
-88.93% |
| 2021-03-31 | Rs171.09 Million ≈ $1.85 Million |
-37.74% |
| 2020-03-31 | Rs274.82 Million ≈ $2.97 Million |
+160.16% |
| 2019-03-31 | Rs105.63 Million ≈ $1.14 Million |
-3.86% |
| 2018-03-31 | Rs109.87 Million ≈ $1.19 Million |
+20.16% |
| 2017-03-31 | Rs91.44 Million ≈ $988.88K |
-30.86% |
| 2016-03-31 | Rs132.25 Million ≈ $1.43 Million |
+147.59% |
| 2015-03-31 | Rs53.42 Million ≈ $577.66K |
-20.70% |
| 2014-03-31 | Rs67.36 Million ≈ $728.45K |
+9.87% |
| 2013-03-31 | Rs61.31 Million ≈ $663.03K |
-15.70% |
| 2012-03-31 | Rs72.73 Million ≈ $786.51K |
+97.67% |
| 2011-03-31 | Rs36.79 Million ≈ $397.89K |
-56.84% |
| 2010-03-31 | Rs85.25 Million ≈ $921.94K |
+18.42% |
| 2009-03-31 | Rs71.99 Million ≈ $778.51K |
-8.89% |
| 2008-03-31 | Rs79.01 Million ≈ $854.46K |
-- |
About Biofil Chemicals & Pharmaceuticals Limited
Biofil Chemicals and Pharmaceuticals Limited engages in manufacturing and trading of pharmaceuticals in India. It operates through Pharmaceutical and Chemical divisions. The company offers basic drugs and chemicals, such as sodium chloride, potassium chloride, sodium citrate, diethyl carbamazine citrate, ferrous sulphate, dried ferrous sulphate, ferrous fumerate, micro crystalline cellulose, and … Read more